Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IGF-II R/IGF2R Antibody (MEM-238), DyLight 650, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NB500464C

Catalog No. NB500464C


Only null left
Add to Cart

Description

Description

IGF-II R/IGF2R Monoclonal specifically detects IGF-II R/IGF2R in Human, Primate samples. It is validated for Western Blot, Flow Cytometry.
Specifications

Specifications

IGF-II R/IGF2R
Monoclonal
DyLight 650
50 mM sodium borate with 0.05% sodium azide
IGF2R
Recombinant Vaccinia virus encoding CD222.
Primary
The antibody MEM-238 recognizes an epitope between domains 2 and 5 of CD222 (IGF2 receptor), a ubiquitously expressed 250 kDa multifunctional type I transmembrane protein. The majority of CD222 is found in the late endosomal/prelysosomal ompartment, 5-10% in the plasma membrane and the truncated (220 kDa) form of CD222 is present in human and bovine serum.
Store at 4°C in the dark.
Western Blot, Flow Cytometry
MEM-238
Western Blot, Flow Cytometry
300 kDa mannose 6-phosphate receptor, cation-independent mannose-6 phosphate receptor, cation-independent mannose-6-phosphate receptor, CD222, CD222 antigen, CI Man-6-P receptor, CIMPR, CI-MPR, IGF-II receptor, insulin-like growth factor 2 receptorM6P/IGF2R, Insulin-like growth factor II receptor, M6P/IGF2 receptor, M6PR, M6P-R, MPR 300, MPR1, MPRIM6PR
Mouse
0.1 mL
3482
Human, Primate
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.